Current Size: 100%

Annual ERIA Meeting 2013

group picture of the participants of the ERIA annual meeting 2013. Image: Lukas Kenner

European Research Initiative on ALK-related Malignancies hold its annual meeting at
National Center of Tumor Diseases (NCT) / German Cancer Research Center (DKFZ) Heidelberg, Germany

Organisers: Olaf Merkel, Suzanne Turner, Lukas Kenner, Thorsten Zenz

About ERIA
The European Research Initiative on ALK-related malignancies (ERIA) was conceived at the American Association for Cancer Research 100th Annual Meeting in Denver, CO, USA back in 2009 by Suzanne Turner, Olaf Merkel and Lukas Kenner.
Our aim is to strengthen cooperation and partnership of European research groups focused on ALK-related malignancies in order to accelerate scientific progress. With this aim in mind we anticipate that more efficacious and less toxic therapeutic
strategies will be developed.

The scientific presentations at the annual meeting 2013 included

ALK mutations and mechanisms of transformation in neuroblastoma

Prof. A. T. Look, Boston, USA

Update on the Crizotinib trial in ALCL

Prof. C. Gambacorti-Passerini, Milano-Bicocca, Italy

A new transgenic mouse model for T cell lymphoma / leukemia in the CD8 T cell lineage

Richard Moriggl, Vienna, Austria

Event Info
Thursday, 27. June 2013 - 9:30 to Friday, 28. June 2013 - 18:30
Heidelberg, Germany